Solid organs transport fluids through distinct vascular networks that are biophysically and
biochemically entangled, creating complex three-dimensional (3D) transport regimes that …

Bioluminescent imaging (BLI) is a non‐invasive imaging modality widely used in the field of
pre‐clinical oncology research. Imaging of small animal tumour models using BLI involves …

Bioluminescence is a ubiquitous imaging modality for visualizing biological processes in
vivo. This technique employs visible light and interfaces readily with most cell and tissue …

Tracking the fate and function of cells in vivo is paramount for the development of rational
therapies for cardiac injury. Bioluminescence imaging (BLI) provides a means for monitoring …

Imaging technologies based on chemiluminescence (CL) and bioluminescence (BL) have
seen a tremendous growth in the past decade due to their extensive contributions to …

Molecular and non‐invasive imaging are rapidly emerging fields in preclinical cancer drug
discovery. This is driven by the need to develop more efficacious and safer treatments, the …

Certain bacteria have emerged as biological gene vectors with natural tumor specificity,
capable of specifically delivering genes or gene products to the tumor environment when …

Bioluminescence imaging (BLI), an optical preclinical imaging modality, is an invaluable
imaging modality due to its low-cost, high throughput, fast acquisition times, and functional …

Live animal imaging is becoming an increasingly common technique for accurate and
quantitative assessment of tumor burden over time. Bioluminescence imaging systems rely …

Bioluminescence imaging (BLI) enables in vivo imaging of molecular and cellular
processes. It has gained in popularity over the past decade because of its easy translation …